Clinical trials
Completed Pain trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
209 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 11 |
| 2012 | 8 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 10 |
| 2016 | 11 |
| 2017 | 7 |
| 2018 | 14 |
| 2019 | 13 |
| 2020 | 14 |
| 2021 | 23 |
| 2022 | 14 |
| 2023 | 18 |
| 2024 | 12 |
| 2025 | 10 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 209 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Valencia | 11 |
| Universidad de Granada | 8 |
| University of Seville | 8 |
| Cardenal Herrera University | 6 |
| Grünenthal GmbH | 6 |
| Universidad Católica de Ávila | 5 |
| Universidad Rey Juan Carlos | 5 |
| Universidad de Murcia | 5 |
| University of Castilla-La Mancha | 5 |
| Janssen Research & Development, LLC | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pain | 209 |
| Fibromyalgia | 25 |
| Agnosia | 15 |
| Chronic Pain | 12 |
| Low Back Pain | 12 |
| Anxiety Disorders | 11 |
| Osteoarthritis | 11 |
| Osteoarthritis, Knee | 11 |
| Postoperative Pain | 8 |
| Pelvic Pain | 6 |
Trials
Showing 1 to 25 of 209. Each trial links to its page on Pharma Observatory.
109 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.